Cargando…

Nonatopic Eosinophilic Esophagitis in an Adult

Eosinophilic esophagitis (EoE) is an inflammatory condition limited to the esophagus, predominantly consisting of eosinophils, and triggered by hypersensitivity reactions. Recurrent dysphagia secondary to EoE is uncommon in patients with no history of asthma and/or atopic conditions. We are presenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Ivanna, Phrathep, Davong D, Healey, Kevin D, Anthony, Stefan, Herman, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795082/
https://www.ncbi.nlm.nih.gov/pubmed/36582585
http://dx.doi.org/10.7759/cureus.31967
_version_ 1784860176506945536
author Ward, Ivanna
Phrathep, Davong D
Healey, Kevin D
Anthony, Stefan
Herman, Michael
author_facet Ward, Ivanna
Phrathep, Davong D
Healey, Kevin D
Anthony, Stefan
Herman, Michael
author_sort Ward, Ivanna
collection PubMed
description Eosinophilic esophagitis (EoE) is an inflammatory condition limited to the esophagus, predominantly consisting of eosinophils, and triggered by hypersensitivity reactions. Recurrent dysphagia secondary to EoE is uncommon in patients with no history of asthma and/or atopic conditions. We are presenting a case of a 48-year-old male suffering from dysphagia for 10 years that worsened over a six-month period. The patient reported no known food and drug allergies, asthma, and other atopic conditions. On esophagogastroduodenoscopy (EGD), the patient fulfilled all five endoscopic reference score (EREFS) criteria, granting a final diagnosis of eosinophilic esophagitis with a score of 6. Biopsy confirmed eosinophilic esophagitis, revealing 20 eosinophils/high-power fields. Skin prick testing was negative. His symptoms had improved at the office follow-up after three weeks after esophageal dilation and proton pump inhibitor (PPI) but did not completely resolve. The patient was then started on fluticasone 440 mcg two times a day. After eight weeks, the patient was symptom-free by taking dual therapy of PPI and fluticasone. The patient was advised to continue taking the daily PPI and then a six-week course of fluticasone if he experienced an exacerbation in his symptoms. In this report, symptom improvement with esophageal dilation, PPI, and fluticasone suggested a successful treatment regimen for EoE in the setting of no known atopy in our patient. Our case highlights EoE in an adult with no known asthma and allergies. The report identifies the importance of a prompt clinical diagnosis and appropriate combination treatment due to the progressive pain and its worsening associated with eosinophilic esophagitis.
format Online
Article
Text
id pubmed-9795082
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97950822022-12-28 Nonatopic Eosinophilic Esophagitis in an Adult Ward, Ivanna Phrathep, Davong D Healey, Kevin D Anthony, Stefan Herman, Michael Cureus Internal Medicine Eosinophilic esophagitis (EoE) is an inflammatory condition limited to the esophagus, predominantly consisting of eosinophils, and triggered by hypersensitivity reactions. Recurrent dysphagia secondary to EoE is uncommon in patients with no history of asthma and/or atopic conditions. We are presenting a case of a 48-year-old male suffering from dysphagia for 10 years that worsened over a six-month period. The patient reported no known food and drug allergies, asthma, and other atopic conditions. On esophagogastroduodenoscopy (EGD), the patient fulfilled all five endoscopic reference score (EREFS) criteria, granting a final diagnosis of eosinophilic esophagitis with a score of 6. Biopsy confirmed eosinophilic esophagitis, revealing 20 eosinophils/high-power fields. Skin prick testing was negative. His symptoms had improved at the office follow-up after three weeks after esophageal dilation and proton pump inhibitor (PPI) but did not completely resolve. The patient was then started on fluticasone 440 mcg two times a day. After eight weeks, the patient was symptom-free by taking dual therapy of PPI and fluticasone. The patient was advised to continue taking the daily PPI and then a six-week course of fluticasone if he experienced an exacerbation in his symptoms. In this report, symptom improvement with esophageal dilation, PPI, and fluticasone suggested a successful treatment regimen for EoE in the setting of no known atopy in our patient. Our case highlights EoE in an adult with no known asthma and allergies. The report identifies the importance of a prompt clinical diagnosis and appropriate combination treatment due to the progressive pain and its worsening associated with eosinophilic esophagitis. Cureus 2022-11-28 /pmc/articles/PMC9795082/ /pubmed/36582585 http://dx.doi.org/10.7759/cureus.31967 Text en Copyright © 2022, Ward et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Ward, Ivanna
Phrathep, Davong D
Healey, Kevin D
Anthony, Stefan
Herman, Michael
Nonatopic Eosinophilic Esophagitis in an Adult
title Nonatopic Eosinophilic Esophagitis in an Adult
title_full Nonatopic Eosinophilic Esophagitis in an Adult
title_fullStr Nonatopic Eosinophilic Esophagitis in an Adult
title_full_unstemmed Nonatopic Eosinophilic Esophagitis in an Adult
title_short Nonatopic Eosinophilic Esophagitis in an Adult
title_sort nonatopic eosinophilic esophagitis in an adult
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795082/
https://www.ncbi.nlm.nih.gov/pubmed/36582585
http://dx.doi.org/10.7759/cureus.31967
work_keys_str_mv AT wardivanna nonatopiceosinophilicesophagitisinanadult
AT phrathepdavongd nonatopiceosinophilicesophagitisinanadult
AT healeykevind nonatopiceosinophilicesophagitisinanadult
AT anthonystefan nonatopiceosinophilicesophagitisinanadult
AT hermanmichael nonatopiceosinophilicesophagitisinanadult